| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/29/2011 | WO2011118060A1 Method for screening intestinal immunity suppression agents |
| 09/29/2011 | WO2011117625A1 Continuous culture of anaerobic solvent-producing bacteria |
| 09/29/2011 | WO2011116969A1 Method for promoting the growth of algae or cyanobacteria in an aqueous solution |
| 09/29/2011 | WO2011116708A1 Method of changing plants' characters |
| 09/29/2011 | WO2011116649A1 Culturing method for cordyceps militaris |
| 09/29/2011 | WO2011071829A3 Heterologous expression of urease in anaerobic, thermophilic hosts |
| 09/29/2011 | WO2011070214A8 Conjugates and compositions for immunotherapy and anti-tumor treatment |
| 09/29/2011 | US20110239333 Polypeptides Having Xylanase Activity And Polynucleotides Thereof |
| 09/29/2011 | US20110239331 Insecticidal Compounds and Methods for Selection Thereof |
| 09/29/2011 | US20110239325 Polynucleotide sequence of fruit softening associated a-mannosidase and its uses for enhancing fruit shelf life |
| 09/29/2011 | US20110239316 ANTI-cMET ANTIBODY |
| 09/29/2011 | US20110239315 Modular dna-binding domains and methods of use |
| 09/29/2011 | US20110237779 Cdr-repaired antibodies |
| 09/29/2011 | US20110237644 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof |
| 09/29/2011 | US20110237509 hGH AND METHODS FOR PREPARING hGH |
| 09/29/2011 | US20110237501 Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1 |
| 09/29/2011 | US20110237485 Chrysosporium Cellulase and Methods of Use |
| 09/29/2011 | US20110237451 Competitive n-hybrid system |
| 09/29/2011 | US20110237448 Carbohydrate binding module with affinity for insoluble xylan |
| 09/29/2011 | US20110237433 Bacterial extract elicitor |
| 09/29/2011 | US20110236970 Chamber of a bioreactor platform |
| 09/29/2011 | US20110236968 Humanized antibodies against monocyte chemotactic proteins |
| 09/29/2011 | US20110236967 Promiscuous her-2/neu cd4 t cell epitopes |
| 09/29/2011 | US20110236958 Multistory Bioreaction System for Enhancing Photosynthesis |
| 09/29/2011 | US20110236955 Arylacylamidase gene and method of using the same |
| 09/29/2011 | US20110236943 Bioprocessing ligno-cellulose into ethanol with recombinant clostridium |
| 09/29/2011 | US20110236942 Reduced by-product accumulation for improved production of isobutanol |
| 09/29/2011 | US20110236941 Recombinant microorganism and methods of production thereof |
| 09/29/2011 | US20110236936 Method for enhancing production polyhydroxyalkanoic acid from microorganism strains |
| 09/29/2011 | US20110236935 Oxidation process |
| 09/29/2011 | US20110236934 Production of globosides oligosaccharieds using metabolically engineered microorganisms |
| 09/29/2011 | US20110236933 RECOMBINANT EUKARYOTIC EXPRESSION PLASMID ENCODING pprI GENE OF DEINOCOCCUS RADIODURANS R1 AND ITS FUNCTIONS |
| 09/29/2011 | US20110236929 E. coli bl21 strain lacking a functional group ii capsular gene cluster |
| 09/29/2011 | US20110236928 Methods for producing polypeptides in enzyme-deficient mutants of fusarium venenatum |
| 09/29/2011 | US20110236926 Host Cells and Methods Of Producing Disulfide Bond Containing Proteins |
| 09/29/2011 | US20110236900 Novel muts protein and method for determing mutation using the same |
| 09/29/2011 | US20110236886 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 09/29/2011 | US20110236531 Glyceroglycolipid lipase |
| 09/29/2011 | US20110236530 Genetic Cluster of Strains of Streptococcus Thermophilus Having Unique Rheological Properties for Dairy Fermentation |
| 09/29/2011 | US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/29/2011 | US20110236416 Foot and mouth disease virus recombinant vaccines and uses thereof |
| 09/29/2011 | US20110236410 Klebsiella antigens |
| 09/29/2011 | US20110236390 IL-17A Antagonists |
| 09/29/2011 | US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof |
| 09/29/2011 | US20110236388 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies |
| 09/29/2011 | US20110236380 Ligands that bind il-13 |
| 09/29/2011 | US20110236375 Antibody variants with enhanced complement activity |
| 09/29/2011 | US20110236361 Effective control of viral plant disease with strains of pseudomonas oleovorans |
| 09/29/2011 | US20110236360 Lactic acid bacterium having high oxalic acid decomposition ability |
| 09/29/2011 | US20110236359 Antimicrobial Activity of Bacteriocin-Producing Lactic Acid Bacteria |
| 09/29/2011 | US20110236353 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 09/29/2011 | US20110236339 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236338 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236337 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236336 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236335 Perhydrolase providing improved specific activity |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | US20110232344 Concentration of algal biomass |
| 09/29/2011 | US20110232179 Grg23 epsp synthases: compositions and methods of use |
| 09/29/2011 | DE19641876B4 Streptavidinmuteine Streptavidin muteins |
| 09/29/2011 | DE102010012921A1 Verfahren zur Förderung des Wachstums von Algen oder Cyanobakterien in einer wässrigen Lösung A method for promoting the growth of algae or cyanobacteria in an aqueous solution |
| 09/29/2011 | CA2781516A1 Culture medium for specific growth, detection, and enumeration of bifidobacterium breve |
| 09/29/2011 | CA2771139A1 Measurement method for viable cell count, and culture medium |
| 09/28/2011 | EP2369005A1 Biological active proteins having increased in vivo and/or in vitro stability |
| 09/28/2011 | EP2369002A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 09/28/2011 | EP2368987A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/28/2011 | EP2368986A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 09/28/2011 | EP2368977A1 Mutant luciferase having increased thermostability |
| 09/28/2011 | EP2368976A1 Mutant luciferase having increased thermostability |
| 09/28/2011 | EP2368961A1 Oil extraction substance |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368907A2 Anti-Abeta antibodies and their use |
| 09/28/2011 | EP2368444A1 Yeast extract with high glutamic acid content and producing method thereof |
| 09/28/2011 | EP2367950A2 Production of omega-3 fatty acids by myxobacteria |
| 09/28/2011 | EP2367949A1 Production of branched-chain alcohols by photosynthetic microoraganisms |
| 09/28/2011 | EP2367928A1 Xylose isomerase genes and their use in fermentation of pentose sugars |
| 09/28/2011 | EP2367927A1 Electrospun polymer fibers comprising particles of bacteria-containing hydrogels |
| 09/28/2011 | EP2367628A1 Peptides mimicking urease, methods of manufacturing, application in diagnostic tests and the way of performance the test |
| 09/28/2011 | EP2367568A2 Meningococcal vaccines including hemoglobin receptor |
| 09/28/2011 | EP2124976B1 Growth inhibition and elimination of methicillin-resistant staphylococcus aureus by lactic acid bacteria |
| 09/28/2011 | EP2121918B1 L-threonine overproducing microorganism and method for preparing l-threonine using the same |
| 09/28/2011 | EP1814987B1 L-amino acid-producing bacterium and a method for producing l-amino acid |
| 09/28/2011 | EP1649041B1 Multimeric oxidoreductases |
| 09/28/2011 | EP1576094B1 Methods of creating modified promoters resulting in varying levels of gene expression |
| 09/28/2011 | EP1506005B1 Methods for the in vitro culture of sporozoea sp. and use thereof |
| 09/28/2011 | EP1479762B1 Novel dehydrogenase and gene encoding the same |
| 09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
| 09/28/2011 | EP1403373B1 Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system |
| 09/28/2011 | EP0777732B1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 09/28/2011 | CN1973039B Stabilized proline transporter |
| 09/28/2011 | CN1826059B Composition containing lactic acid bacterium producing equol |
| 09/28/2011 | CN1630712B Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 09/28/2011 | CN1346369B Method and compositions for the prevention and treatment of anamia |
| 09/28/2011 | CN102204002A Microbial fuel cell |
| 09/28/2011 | CN102203268A Siderophore-mediated iron uptake in bacterial infection |
| 09/28/2011 | CN102203248A Tannase, gene encoding same, and process for producing same |
| 09/28/2011 | CN102203238A Scyllo-inositol-producing cell and scyllo-inositol production method using said cells |
| 09/28/2011 | CN102203237A Sporulation-deficient thermophilic microorganisms for the production of ethanol |
| 09/28/2011 | CN102203236A A composition for activating and/or stabilizing micro-organisms |
| 09/28/2011 | CN102202685A Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |